Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Hum&C Co. Ltd. (263920:KRX), powered by AI.
Hum&C Co. Ltd. is currently trading at ₩3,330. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Hum&C Co. Ltd. on Alpha Lenz.
Hum&C Co. Ltd.'s P/E ratio is 19.8.
“Hum&C Co. Ltd. trades at a P/E of 19.8 (fair value) with modest ROE of 3.5%. 3Y revenue CAGR of 13.7% highlights clear growth momentum.”
Ask for details →Hum&C Co. Ltd. is a South Korea-based company primarily engaged in the biotechnology sector. The company specializes in the research, development, and production of health-oriented goods and services, including dietary supplements and beauty products. Hum&C Co. Ltd. leverages cutting-edge scientific research to create products that cater to the growing consumer demand for wellness and beauty solutions. As a player in the burgeoning biotechnology industry in South Korea, the company supports both domestic and international markets by distributing its products through a combination of online channels, strategic partnerships, and retail outlets. By focusing on innovation and quality, Hum&C Co. Ltd. contributes significantly to advancements in health-related biotechnology, influencing lifestyle and consumer behavior trends in the global market.
“Hum&C Co. Ltd. trades at a P/E of 19.8 (fair value) with modest ROE of 3.5%. 3Y revenue CAGR of 13.7% highlights clear growth momentum.”
Ask for details →Hum&C Co. Ltd. (ticker: 263920) is a company listed on KRX in the Consumer Defensive sector (Household & Personal Products). It has approximately 168 employees. Market cap is $31.1B.
The current price is ₩3,330 with a P/E ratio of 19.82x and P/B of 0.68x.
ROE is 3.51% and operating margin is 5.12%. Annual revenue is $52.3B.